Table 3.

Clinical outcomes of MDS-Eos, MDS-Bas, and MDS−/− patients

MDS-Eos,
n = 36		MDS-Bas,
n = 34		MDS−/−,
n = 229		P
No. of deaths 27 (75%) 27 (79%) 147 (64%) NS 
Cause of death    NS 
 AML3-150 13 14 65  
 BMF 12 11 61  
 TRM 0 0 6  
 Others 2 2 15  
MDS-Eos,
n = 36		MDS-Bas,
n = 34		MDS−/−,
n = 229		P
No. of deaths 27 (75%) 27 (79%) 147 (64%) NS 
Cause of death    NS 
 AML3-150 13 14 65  
 BMF 12 11 61  
 TRM 0 0 6  
 Others 2 2 15  

BMF indicates bone marrow failure; and TRM, therapy-related mortality.

F3-150

Evolution to AML was diagnosed when the bone marrow blast percentage exceeded 30%.

View Large